The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Reports |

Possible Bromocriptine-Induced Myocardial Infarction

Fabrice Larrazet, MD; Christian Spaulding, MD; Henri J. Lobreau, MD; Simon Weber, MD; and Francois Guerin, MD
[+] Article, Author, and Disclosure Information

From the CHU Cochin Port Royal, Paris, France. Requests for Reprints: Simon Weber, MD, Service de Cardiologie, 27 rue du faubourg Saint-Jacques, 75014 Paris, France.

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 1993;118(3):199-200. doi:10.7326/0003-4819-118-3-199302010-00008
Text Size: A A A

We report a case of a postpartum myocardial infarction in a 32-year-old multiparous woman receiving bromocriptine. The patient had an uncomplicated pregnancy. She had been sent home with bromocriptine to suppress lactation. Ten days postpartum, she presented with chest pain. Her electrocardiogram showed marked ST-segment elevation in leads II, III, and aVF. Coronary angiography showed a total occlusion of the midportion of the right coronary artery. Angioplasty was immediately done, and the right coronary artery was reopened. One month later, she was tested with bromocriptine. At the peak of action of bromocriptine, a severe narrowing of the right coronary artery occurred, which probably corresponded to a bromocriptine-induced spasm. Bromocriptine is an ergopeptine derivative, and it should be considered as a possible etiologic agent causing postpartum myocardial infarction in patients with a predisposition to coronary vasospasm.


Grahic Jump Location
Figure 1.
Coronary angiogram of the right coronary artery.Left.arrowRight.

Bromocriptine-induced spasm of the artery ( ). The arterial constriction disappears after intracoronary nitroglycerin.

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.